Phanes Therapeutics
PrivateLast Round
Series B
May 25, 2021
Total Funding Raised
$40M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Phanes Therapeutics is a biotechnology company specializing in drug discovery and early development in immuno-oncology, creating native IgG-like bispecific antibodies that improve drug-like properties to facilitate patient access to innovative therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phanes Therapeutics Comparables
Compare Phanes Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Chimagen Biosciences | 84% | |
| Qure Biotechnology (Shanghai) Co., Ltd. | 78% | |
| APITBIO, Inc. | 77% | |
Phanes Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 25, 2021 | ||||
| Series A | Nov 1, 2018 |
Phanes Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DYEE Capital | Series B |
| 险峰K2VC | Series B, Series A |
| Delos Capital Partners | Series B |
| Volcanics Venture | Series B |
| HongShan Capital Group (HSG) | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Updated Phase 2 results for spevatamig to be presented at ASCO Annual Meeting.
- Mar 18, 2026
Presenting three clinical posters at AACR 2026.
Phanes Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Phanes Therapeutics's valuation, stock price, and market status.